STOCK TITAN

A SPAC III Acquisition Right (ASPCR) 10-K Filings

ASPCR NASDAQ

Here are the 10-K annual reports from A SPAC III Acquisition Corp. Right (ASPCR) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 10-K covers the audited annual report, with the full financial statements, so if you follow ASPCR and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ASPCR filings page.

Rhea-AI Summary

A SPAC III Acquisition Corp., a British Virgin Islands blank check company, filed its annual report describing progress toward completing a business combination and key structural changes. The company raised $60,000,000 in its IPO and related private placements, placing those proceeds in a trust account for future redemptions and a merger.

During 2025 it signed a Merger Agreement with Bioserica International Limited, a BVI holding company with operations primarily in China, valuing the acquisition at $217,860,000, payable in newly issued PubCo Class A and Class B ordinary shares. Shareholders approved extending the deadline to complete a business combination to November 12, 2026, and 5,717,419 Class A ordinary shares were redeemed in connection with that vote. As of December 31, 2025, $2,979,936 remained in the trust account and, as of March 4, 2026, 2,337,481 Class A and 100 Class B ordinary shares were outstanding.

The report emphasizes that the company has not begun operations and will not generate operating revenue until after an initial business combination. It describes extensive legal and regulatory risks tied to acquiring a China-based business, including PRC foreign investment, data security, cybersecurity review, VIE structures, and the Holding Foreign Companies Accountable Act, as well as potential CFIUS review if it acquires certain U.S. businesses.